Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls.

Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J.

Lancet. 2006 Feb 25;367(9511):651-8. Review.

PMID:
16503463
2.

Prothrombotic genetic risk factors in young survivors of myocardial infarction.

Ardissino D, Mannucci PM, Merlini PA, Duca F, Fetiveau R, Tagliabue L, Tubaro M, Galvani M, Ottani F, Ferrario M, Corral J, Margaglione M.

Blood. 1999 Jul 1;94(1):46-51.

3.

The prevalence of C807T mutation of glycoprotein Ia gene among young male survivors of myocardial infarction: a relation with coronary angiography results.

Lewandowski K, Swierczyńska A, Kwaśnikowski P, Elikowski W, Rzeźniczak M.

Kardiol Pol. 2005 Aug;63(2):107-13; discussion114.

PMID:
16136407
4.

Genetic risk factors in myocardial infarction at young age.

Incalcaterra E, Hoffmann E, Averna MR, Caimi G.

Minerva Cardioangiol. 2004 Aug;52(4):287-312. Review.

PMID:
15284679
5.
6.

Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behcet's disease.

Gurgey A, Balta G, Boyvat A.

Blood Coagul Fibrinolysis. 2003 Feb;14(2):121-4.

PMID:
12632020
7.

Prothrombotic gene polymorphisms and atherothrombotic cerebral infarction.

Petrovic D, Milanez T, Kobal J, Bregar D, Potisk KP, Peterlin B.

Acta Neurol Scand. 2003 Aug;108(2):109-13.

PMID:
12859287
8.

Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review.

Boekholdt SM, Bijsterveld NR, Moons AH, Levi M, Büller HR, Peters RJ.

Circulation. 2001 Dec 18;104(25):3063-8.

9.

AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.

Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.

Haematologica. 2008 May;93(5):729-34. doi: 10.3324/haematol.12271. Epub 2008 Apr 2.

10.

No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age.

Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group.

Circulation. 2003 Mar 4;107(8):1117-22.

11.
12.

Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.

Yioti GG, Panagiotou OA, Vartholomatos GA, Kolaitis NI, Pappa CN, Evangelou E, Stefaniotou MI.

Ophthalmic Genet. 2013 Sep;34(3):130-9. doi: 10.3109/13816810.2012.746376. Epub 2013 Jan 4.

PMID:
23289804
13.

Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction.

French JK, Van de Water NS, Sutton TM, Lund M, Gao W, McDowell J, Liu-Stratton Y, Pohorence J, Szymanski D, Goldschmidt-Clermont P, White HD, Browett PJ, Cooke G.

Am Heart J. 2003 Jan;145(1):118-24.

PMID:
12514663
14.

Polymorphisms in the genes for coagulation factor II, V, VII in patients undergoing coronary angiography.

Geng X, Jin GD, Fu GS, Ji MA, Shan J, Wang JA.

J Zhejiang Univ Sci. 2003 May-Jun;4(3):369-73.

PMID:
12765295
15.

The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions.

Pons D, Monraats PS, de Maat MP, Pires NM, Quax PH, van Vlijmen BJ, Rosendaal FR, Zwinderman AH, Doevendans PA, Waltenberger J, de Winter RJ, Tio RA, Frants RR, van der Laarse A, van der Wall EE, Jukema JW.

Thromb Haemost. 2007 Dec;98(6):1323-8.

PMID:
18064331
16.

Polymorphisms of coagulation/fibrinolysis genes: gene environment interactions and vascular risk.

Grant PJ.

Prostaglandins Leukot Essent Fatty Acids. 1997 Oct;57(4-5):473-7. Review.

PMID:
9430399
17.

Genetic polymorphisms and coronary artery disease in the south of France.

Canavy I, Henry M, Morange PE, Tiret L, Poirier O, Ebagosti A, Bory M, Juhan-Vague I.

Thromb Haemost. 2000 Feb;83(2):212-6.

PMID:
10739375
19.

Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction.

Redondo M, Watzke HH, Stucki B, Sulzer I, Biasiutti FD, Binder BR, Furlan M, Lämmle B, Wuillemin WA.

Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):1020-5.

20.

Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria.

Renner W, Köppel H, Hoffmann C, Schallmoser K, Stanger O, Toplak H, Wascher TC, Pilger E.

Thromb Res. 2000 Jul 1;99(1):35-9.

PMID:
10904101

Supplemental Content

Support Center